BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026)

BeyondSpring (BYSI) posted Total Current Liabilities of $12.4 million for Q1 2026, down 8.88% sequentially from $13.6 million in Q4 2025, and down 2.33% YoY from $12.7 million in Q1 2025.

BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026) Analysis & Trends

BeyondSpring has reported Total Current Liabilities for 12 years, with the latest figure at $12.4 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 2.33% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (down 2.33% YoY) and the FY2025 annual result came in at $13.6 million, up 23.31% from the prior year.
  • Total Current Liabilities retreated to $12.4 million in Q1 2026 per BYSI's latest filing, from $13.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $13.6 million in Q4 2025 and troughed at $6.8 million in Q2 2023.
  • A 5-year average of $10.5 million and a median of $11.1 million in 2022 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 51.49% in 2022, then jumped 43.28% in 2025.
  • Over 5 years, Total Current Liabilities stood at $7.4 million in 2022, then increased by 8.24% to $8.0 million in 2023, then jumped by 38.35% to $11.0 million in 2024, then climbed by 23.31% to $13.6 million in 2025, then slipped by 8.88% to $12.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $12.4 million, $13.6 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.58 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.51 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 438.74 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 630.93 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 2.49 Bn
10 BeyondSpring 30.22 Mn 30.22 Mn - 14.19 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.19 Mn
Mar 31, 2026 12.37 Mn
Dec 31, 2025 13.58 Mn
Sep 30, 2025 12.89 Mn
Jun 30, 2025 11.73 Mn
Mar 31, 2025 12.67 Mn
Dec 31, 2024 11.01 Mn
Jun 30, 2024 8.19 Mn
Dec 31, 2023 7.96 Mn
Jun 30, 2023 6.82 Mn
Dec 31, 2022 7.35 Mn
Jun 30, 2022 11.11 Mn
Dec 31, 2021 15.16 Mn
Sep 30, 2021 18.56 Mn
Jun 30, 2021 16.57 Mn
Mar 31, 2021 12.63 Mn
Dec 31, 2020 13.77 Mn
Sep 30, 2020 12.82 Mn
Jun 30, 2020 11.31 Mn
Mar 31, 2020 12.21 Mn